Select Clinical Network runs a tightly managed group of study sites that reflect the supervisory skills of a highly professional corporate team. Unlike the loose structure of an SMO, our organization relies upon hands-on attention to detail. Each management team member offers vast experience, research savvy and the skill to facilitate your studies in an efficient, expedient manner.
Rene brings 15 years of professional and leadership experience to SCN. Among his broad investing and operating background in private equity, Rene has direct experience in the biopharmaceutical and CRO space.
As Chief Operative Officer, has launched and managed several successful clinical research sites over the course of his 18-year career. He has worked in every facet of the industry, including conducting phase one studies with many leading CROs and Sponsors.
His goal has always been to create a network of clinical sites unlike a SMO that is able to achieve high enrollment while ensuring the highest quality data.
“Our success is contributed to having a well-educated and diverse corporate team that is able to keep its finger on the pulse at all times, unlike a SMO we are a hands-on organization that knows how to achieve high enrollment while providing high quality data”
brings over 25 years of financial leadership experience to SCN, partnering with investment sponsors and leadership teams in rapidly growing organizations.
With a broad understanding of operations, technology, sales, and human resources, Jim’s inclusive leadership approach promotes collaboration across the organization to develop results-focused strategies and outcomes. Jim is passionate about inspiring and collaborating towards sustainable, exceptional performance. He holds an MBA in both Finance and Information Technology, and is a CPA.
As Vice President of Operations, brings over 18+ years of experience to SCN. This spans clinical strategy and operations, clinical trial management, and project execution, ensuring seamless planning and implementation of clinical programs from Phase I to Phase III.
Her key strengths include building and empowering high-performing teams and enhancing program success, ensuring high-quality outcomes for clinical initiatives.
Board Certified Internist and Gastroenterologist bringing 40 years of medical experience to SCN.
Dr. Darani is a published KOL on vaccine trials that has completed over a 100 clinical trials throughout his esteemed career in Southern California.
brings to SCN 10+ years of marketing experience in pharmaceutical and biotechnology industries, driving leads heading the patient recruitment marketing team.
Marina and her patient recruitment marketing team ensures around-the-clock engagement with potential participants, engaging through digital and social platforms to ensure leads and referrals.
As Vice President of Quality Assurance, has spent the last decade perfecting our quality standards and procedures.
Sarah and her team of quality inspectors understand the level of detail it takes to deliver a quality product, that’s why we inspect every chart at every visit before a subject leaves the clinic. “We take pride in the positive feedback we receive from our Sponsors, which in turn earns us repeat business. Quality is a never-ending process that we will never be truly satisfied with and we will always be striving to raise the bar against our competitors!”
With his extensive experience and proven track record working with sponsors, partners, and investors to advance critical new therapies, Chip will play a pivotal role in helping ECN continue to grow and meet the increasingly demanding and complex requirements of today’s research studies. Chip’s sector experience includes more than a decade at Quintiles (now IQVIA) where as a member of NovaQuest, the strategic investing and partnering arm of Quintiles, he led a global team that worked with emerging and mid-size biotechs to advance new therapies. Following Quintiles, Chip served as CEO of Cognitive Research Corporation, a rapidly growing, therapeutically focused CRO targeting the CNS markets.
MD brings over 25 years of clinical trial experience to SCN.
He has served as an Investigator for over 350 clinical trials.
